European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder - Coghill, David; Banaschewski, Tobias (European neuropsychopharmacology, 2013)
Gesehen am: 30.07.2014